Health Care

Notable Stock Analysts Ratings Esperion Therapeutics, Inc. (ESPR)

Notable Stock Analysts Ratings Esperion Therapeutics, Inc. (ESPR)

The Relative Volume of the company is 12.03 and Average Volume (3 months) is 787.81 million. -32.64% away from the high and 151.81% from the low.

Its last month's stock price volatility remained 10.30% which for the week stands at 10.34%. Over the last week of the month, it was -23.89%, 92.60% over the last quarter, and 110.59% for the past six months. Esperion Therapeutics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0. The Mean and Low price Targets are $2.5 and $0.25, respectively. The biopharmaceutical company reported ($1.29) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.24) by $0.05.

Esperion Therapeutics Inc (NASDAQ:ESPR) shares reached a new 52-week high during mid-day trading on Monday after Needham & Company raised their price target on the stock to $58.00. The stock has its 52-Week High on Mar 8, 2017 and 52-Week Low on Nov 3, 2016. The Market Capitalization of the company stands at 534 Million. Advisor Group Inc. now owns 14,437 shares of the biopharmaceutical company's stock worth $200,000 after buying an additional 85 shares in the last quarter.

The company's stock now has 534 Million in market capitalization. The stock is up 22.19% in this year through last close, and the beta ratio has a value of 0.94.

According to Finviz reported data, The SMA20 of the stock is at -16.97%, SMA50 is 17.71 percent, while SMA200 is 65.99%.

While Looking at Sales Growth (Year/est), the company is now showing a percentage value of -81.4 percent.

The company's ATR (Average True Range) is 2.92. The volatility rate is 10.30% percent and 10.34% percent each.

ESPR), the lipid administration company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), recently declared the initiation of a Phase 2 clinical study (1002-038) to assess the efficacy and safety of triplet oral therapy with bempedoic acid, ezetimibe and atorvastatin in patients with hypercholesterolemia. (NASDAQ:ESPR). At the time of writing, the First Call consensus price target for the company is $30.90. Advisor Group Inc. increased its position in Esperion Therapeutics by 0.6% in the third quarter.

For the quarter ending 11/03/2016, The Analyst projected that the company could deliver EPS of -0.82 while the company provided its Actual EPS of -0.77 showing a difference of 0.05 Percent between the Estimated and Actual EPS.

  • DNA identifies student missing since 1998 in New River Gorge

    Horrocks said investigators found Kovack's drivers license with the remains, and the DNA results confirmed their assumptions. State Police carefully removed skeletal remains from a rugged hillside under the New River Gorge Bridge last March.

    ART Advisors LLC Invests $276000 in Nektar Therapeutics (NKTR)

    The fund owned 111,217 shares of the biopharmaceutical company's stock after selling 86,485 shares during the period. The stock boasts a consensus analyst "Buy" rating with the consensus recommendation standing at 1.50.

    Alberta among provinces that have reached health accord with Ottawa

    Nicolas Marceau, the Parti Québécois spokesperson for Quebec-Canada relations, accused Couillard's Liberals of failure.
  • Globalstar (GSAT) Broker Price Targets For The Coming Week

    The current share price indicate that stock is -60.20% away from its one year high and is moving 41.52% ahead of its 52-week low. The company reported the earnings of $-0.11/Share in the last quarter where the estimated EPS by analysts was $-0.02/share.

    Collins says Trump owes America an explanation on wiretap claim

    US investigators say Russian President Vladimir Putin ordered the hacking into the computers at the Democratic National Committee. I would characterize it this way, at the outset of the investigation, there was circumstantial evidence of collusion.

    See Pink Floyd's drummer Nick Mason crash £3m vehicle

    While taking laps, it looks like Mason slid off of the track and drove directly into a wall. Mason and the other drivers all made it through their accidents unscathed.
  • Yogi Adityanath as UP CM: Two slaughterhouses sealed in Allahabad

    BJP President Amit Shah had on Friday asserted the party aims to take up the issue seriously. Please Wait while comments are loading.

    Penelope Cruz Cast as Donatella Versace in FX's VERSACE: AMERICAN CRIME STORY

    Production of Versace: AMERICAN CRIME STORY is scheduled to begin in April and air in 2018 . It will follow the second installment in the franchise, Katrina: American Crime Story.

    New York Paramedic Killed By Man Driving Stolen Ambulance

    Hundreds of people gathered along a block in the Bronx Sunday evening to mourn an FDNY EMT killed on the job. Church at 2345 University the Bronx. "I tried to send her home, she would not go home".
  • Uber President Resigns Citing Differences in Approach to Leadership

    He plans to return to his native Kansas and explore a career in politics, he said in a statement provided by the company. The ride-sharing company was also sued by Google last February for allegedly stealing its self-driving vehicle secrets.

    Rep. Schiff previews FBI director's House hearing on Russia probe

    He said that the hack into the Democratic National Committee was used "to help Donald Trump and harm Hillary Clinton". The House and Senate intelligence committees have jurisdiction over the United State's 17 intelligence agencies.

    Revenue Estimates Analysis Of Groupon, Inc. (GRPN)

    The current share price indicate that stock is -31.31% away from its one year high and is moving 39.73% ahead of its 52-week low. The stock is now moving above its 20-Day Simple Moving Average of 6.44% with the 50-Day Simple Moving Average of 6.44 percent.